Syros Pharmaceuticals, Inc. (SYRS) Net Income (Loss) Attributable to Parent USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2024.
  • Syros Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$3.71 M, a 84.4% increase year-over-year.
  • Syros Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$144 M, a 54.9% decline year-over-year.
  • Syros Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$165 M, a 73.9% decline from 2022.
  • Syros Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$94.7 M, a 9.35% decline from 2021.
  • Syros Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$86.6 M, a 3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$144 M -$3.71 M +$20.1 M +84.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$165 M -$64.4 M -$59.6 M -1249% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$105 M -$40.1 M -$9.89 M -32.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$95.1 M -$36.3 M -$1.78 M -5.15% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$93.3 M -$23.8 M +$1.36 M +5.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$94.7 M -$4.77 M +$19 M +80% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$114 M -$30.3 M -$4.23 M -16.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$109 M -$34.5 M -$12 M -53.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$97.5 M -$25.1 M -$10.9 M -76.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$86.6 M -$23.8 M +$6.32 M +21% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$92.9 M -$26 M -$6.54 M -33.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$86.3 M -$22.5 M -$5.29 M -30.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$81 M -$14.2 M +$3 M +17.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$84 M -$30.1 M -$10.4 M -53% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 -$73.6 M -$19.5 M +$307 K +1.55% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$73.9 M -$17.2 M +$2.26 M +11.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$76.2 M -$17.2 M -$765 K -4.65% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$75.4 M -$19.7 M -$1.64 M -9.07% Oct 1, 2019 Dec 31, 2019 10-Q 2022-11-14
Q3 2019 -$73.8 M -$19.8 M -$4.06 M -25.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$69.7 M -$19.5 M -$5.41 M -38.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$64.3 M -$16.5 M -$2 M -13.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$62.3 M -$18.1 M -$2.76 M -18.1% Oct 1, 2018 Dec 31, 2018 10-Q 2021-11-05
Q3 2018 -$59.5 M -$15.7 M -$1.91 M -13.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$57.6 M -$14 M -$679 K -5.08% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$56.9 M -$14.5 M -$2.95 M -25.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 -$54 M -$15.3 M -$4.33 M -39.5% Oct 1, 2017 Dec 31, 2017 10-Q 2020-11-05
Q3 2017 -$49.7 M -$13.8 M +$344 K +2.43% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$50 M -$13.4 M -$1.35 M -11.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$48.7 M -$11.5 M -$927 K -8.76% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$47.7 M -$11 M -$276 K -2.58% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$47.5 M -$14.2 M -$5.71 M -67.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$41.8 M -$12 M -$5.92 M -97.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$35.8 M -$10.6 M -$6.02 M -132% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$29.8 M -$10.7 M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-20
Q3 2015 -$8.46 M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-20
Q2 2015 -$6.1 M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-20
Q1 2015 -$4.57 M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.